AJP - Renal Physiology, Vol 266, Issue 5 731-F737, Copyright © 1994 by American Physiological Society

ARTICLES

Renal function in hypertensive rats transgenic for mouse renin gene

J. E. Springate, L. G. Feld and D. Ganten
Department of Pediatrics, State University of New York at Buffalo School of Medicine and Biomedical Sciences.

The recent development of a transgenic rat strain carrying the mouse ren-2 renin gene [TGR(mRen2)27] has provided a new model of hypertension characterized by suppressed plasma renin levels and marked hyperproreninemia. In this long-term study, we examined the kidney function of these animals. Transgenic rats had significantly (P < 0.01) higher blood pressures than control animals at 2, 4, and 8 mo of age. However, the severity of their hypertension diminished over time (225 +/- 8 mmHg at age 2 mo vs. 169 +/- 5 mmHg at age 8 mo, P < 0.001), indicating age-dependent transgene regulation. Whole kidney and single-nephron blood flows and glomerular filtration rates did not differ between control and TGR(mRen2)27 animals studied with micropuncture techniques at 4 and 8 mo of age. Preglomerular vasoconstriction was responsible for this normal autoregulatory response. Elevated preglomerular vascular resistance of transgenic rats prevented transmission of systemic hypertension to glomeruli at 4 but not 8 mo of age leading to increased glomerular capillary pressures in these older animals (53 +/- 1 vs. 48 +/- 1 mmHg, P < 0.05). Pathological albuminuria appeared as early as 2 mo of age but did not increase over the subsequent 6 mo of follow-up. The incidence of glomerulosclerosis, assessed at 4 and 8 mo of age, was greater in TGR(mRen2)27 than control animals (6.6 +/- 1.4% vs. 0.9 +/- 0.3%, P = 0.01) but did not differ between 4- and 8-mo-old transgenic rats. Glomerular ultrafiltration coefficients were significantly elevated (P < 0.05) in transgenic rats.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. A. Jessup, P. E. Gallagher, D. B. Averill, K. B. Brosnihan, E. A. Tallant, M. C. Chappell, and C. M. Ferrario Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2166 - H2172. [Abstract] [Full Text] [PDF]

				S. M. Jacinto, J. J. Mullins, and K. D. Mitchell Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats Am J Physiol Renal Physiol, February 1, 1999; 276(2): F315 - F322. [Abstract] [Full Text] [PDF]

				J. Zhuo, M. Ohishi, and F. A. O. Mendelsohn Roles of AT1 and AT2 Receptors in the Hypertensive Ren-2 Gene Transgenic Rat Kidney Hypertension, January 1, 1999; 33(1): 347 - 353. [Abstract] [Full Text] [PDF]

				P. Li, M. Morris, C. M. Ferrario, C. Barrett, D. Ganten, and M. F. Callahan Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1130 - H1137. [Abstract] [Full Text] [PDF]

				J. E. Springate, L. G. Feld, and D. Ganten Enalapril and Renal Function in Hypertensive Rats Transgenic for Mouse Renin Gene Hypertension, October 1, 1997; 30(4): 868 - 872. [Abstract] [Full Text]

				D. J. Campbell, P. Rong, A. Kladis, B. Rees, D. Ganten, and S. L. Skinner Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 Rat Hypertension, May 1, 1995; 25(5): 1014 - 1020. [Abstract] [Full Text]